SUBSCRIBE
SUBSCRIBE
News   Policy

Cornerstone Therapeutics Inc. Gets U.S. FDA Warning

November 23, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators warned Cornerstone Therapeutics that the company has distributed drugs without approved applications, a letter released on Friday said.
Regulatory
MORE ON THIS TOPIC
FDA
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
September 16, 2026
 · 
1 min read
 · 
Jef Akst
Creative concept of leadership and innovation with a glowing blue light bulb leading paper planes. Symbol of advanced technology, AI-driven strategy, and visionary direction in a digital future.
Regulatory
FDA opens Operation TrialBlazer for applications, hoping to reshore early trials
September 15, 2026
 · 
1 min read
 · 
Heather McKenzie
People group with speech bubbles. Banner concept of business, internet discuss, news, social networks, chat, dialogue.
Regulatory
Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meeting
September 15, 2026
 · 
6 min read
 · 
Heather McKenzie
Psychology, Dream, Mental Health concept illustration. Brain, neuroscience and creative mind poster, cover. Vector modern illustration
Psychedelics
Stakeholders urge FDA to define data, treatment standards as psychedelic drugs near market
September 15, 2026
 · 
5 min read
 · 
Michael Gibney